Published in Antimicrob Agents Chemother on July 16, 2012
Engineered bacteriophage lysins as novel anti-infectives. Front Microbiol (2014) 0.95
Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage (2015) 0.92
Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother (2013) 0.85
Biocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and Endolysins. Front Microbiol (2016) 0.82
Isolation and characterization of a novel phage lysin active against Paenibacillus larvae, a honeybee pathogen. Bacteriophage (2015) 0.80
Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa. Front Microbiol (2015) 0.77
A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus. Sci Rep (2017) 0.75
Anthrax. N Engl J Med (1999) 8.89
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
A bacteriolytic agent that detects and kills Bacillus anthracis. Nature (2002) 5.63
ULTRASTRUCTURE OF THE EXOSPORIUM ENVELOPING SPORES OF BACILLUS CEREUS. J Bacteriol (1964) 5.28
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Isolation and characterization of rifampin-resistant and streptolydigin-resistant mutants of Bacillus subtilis with altered sporulation properties. J Bacteriol (1974) 3.54
A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol (2002) 3.26
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
Anthrax vaccines: past, present and future. Vaccine (1991) 2.98
Utilization of the rpoB gene as a specific chromosomal marker for real-time PCR detection of Bacillus anthracis. Appl Environ Microbiol (2001) 2.50
Proteomic analysis of the spore coats of Bacillus subtilis and Bacillus anthracis. J Bacteriol (2003) 2.34
Identification of proteins in the exosporium of Bacillus anthracis. Microbiology (2004) 2.26
Definitive identification of Bacillus anthracis--a review. J Appl Microbiol (1999) 2.01
Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem (2005) 1.79
A field investigation of Bacillus anthracis contamination of U.S. Department of Agriculture and other Washington, D.C., buildings during the anthrax attack of October 2001. Appl Environ Microbiol (2003) 1.76
Characterization of cotJ, a sigma E-controlled operon affecting the polypeptide composition of the coat of Bacillus subtilis spores. J Bacteriol (1995) 1.73
Structural details of anthrax spores during stages of transformation into vegetative cells. J Bacteriol (1966) 1.64
Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J Clin Microbiol (2001) 1.54
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50
Reinventing phage therapy: are the parts greater than the sum? Nat Biotechnol (2006) 1.49
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.48
The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat Protoc (2006) 1.45
Fine filaments on the outside of the exosporium of Bacillus anthracis spores. J Bacteriol (1966) 1.35
COMPARISON OF THE FINE STRUCTURE OF VIRULENT AND AVIRULENT SPORES OF BACILLUS ANTHRACIS. Tex Rep Biol Med (1963) 1.31
UV resistance of Bacillus anthracis spores revisited: validation of Bacillus subtilis spores as UV surrogates for spores of B. anthracis Sterne. Appl Environ Microbiol (2003) 1.20
Loop-mediated isothermal amplification for rapid detection of Bacillus anthracis spores. Biotechnol Lett (2007) 1.14
Scatchard plot: common misinterpretation of binding experiments. Anal Biochem (1980) 1.13
A glycoprotein multimer from Bacillus thuringiensis sporangia: dissociation into subunits and sugar composition. Mol Cell Biochem (1995) 1.08
Surface architecture of endospores of the Bacillus cereus/anthracis/thuringiensis family at the subnanometer scale. Proc Natl Acad Sci U S A (2011) 1.07
Species-specific peptide ligands for the detection of Bacillus anthracis spores. Appl Environ Microbiol (2003) 1.05
Bacillus anthracis incident, Kameido, Tokyo, 1993. Emerg Infect Dis (2004) 1.04
Use of long-range repetitive element polymorphism-PCR to differentiate Bacillus anthracis strains. Appl Environ Microbiol (2001) 1.04
The monitoring and detection of Bacillus anthracis in the environment. Soc Appl Bacteriol Symp Ser (1991) 0.99
Peptide ligands that bind selectively to spores of Bacillus subtilis and closely related species. Appl Environ Microbiol (2003) 0.97
Rapid genotypic detection of Bacillus anthracis and the Bacillus cereus group by multiplex real-time PCR melting curve analysis. FEMS Immunol Med Microbiol (2005) 0.95
Determination of binding parameters from Scatchard plots. Theoretical and practical considerations. Eur J Biochem (1974) 0.94
Construction of single chain variable fragment (ScFv) and BiscFv-alkaline phosphatase fusion protein for detection of Bacillus anthracis. Anal Chem (2006) 0.94
Peptide-based fluorescence resonance energy transfer protease substrates for the detection and diagnosis of Bacillus species. Anal Chem (2011) 0.93
Combined effects of high hydrostatic pressure and temperature for inactivation of Bacillus anthracis spores. Appl Environ Microbiol (2004) 0.92
Identification of Bacillus anthracis specific chromosomal sequences by suppressive subtractive hybridization. BMC Genomics (2004) 0.91
Real-time PCR assay for rapid detection of Bacillus anthracis spores in clinical samples. J Clin Microbiol (2002) 0.91
Performance evaluation of five commercial real-time PCR reagent systems using TaqMan assays for B. anthracis detection. Clin Biochem (2008) 0.91
Sensitive detection of Bacillus anthracis using a binding protein originating from gamma-phage. Microbiol Immunol (2007) 0.87
Gamma-phage lysin PlyG sequence-based synthetic peptides coupled with Qdot-nanocrystals are useful for developing detection methods for Bacillus anthracis by using its surrogates, B. anthracis-Sterne and B. cereus-4342. BMC Biotechnol (2009) 0.86
2-D reference map of Bacillus anthracis vaccine strain A16R proteins. Proteomics (2005) 0.85
Identification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of gamma-phage, PlyG, to Bacillus anthracis. Biochem Biophys Res Commun (2007) 0.85
Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies. PLoS One (2009) 0.84
Detection of virulence-associated genes in clinical isolates of bacillus anthracis by multiplex PCR and DNA probes. J Microbiol Biotechnol (2009) 0.84
Characterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis. FEMS Microbiol Lett (2008) 0.84
Antibody-based systems for the detection of bacillus anthracis in environmental samples J Appl Microbiol (1999) 0.82
Label-free detection of B. anthracis spores using a surface plasmon resonance biosensor. Analyst (2009) 0.82
Detection of Escherichia coli enoyl-ACP reductase using biarsenical-tetracysteine motif. Bioconjug Chem (2010) 0.81
Label-free optical detection of anthrax-causing spores. J Am Chem Soc (2007) 0.81
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet (2013) 1.95
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res (2010) 1.60
Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.51
Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. FEBS J (2008) 1.49
Identification and characterization of catabolic para-nitrophenol 4-monooxygenase and para-benzoquinone reductase from Pseudomonas sp. strain WBC-3. J Bacteriol (2009) 1.37
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol (2008) 1.35
Increased dopamine level enhances male-male courtship in Drosophila. J Neurosci (2008) 1.31
Imaging and characterizing influenza A virus mRNA transport in living cells. Nucleic Acids Res (2008) 1.26
Split mCherry as a new red bimolecular fluorescence complementation system for visualizing protein-protein interactions in living cells. Biochem Biophys Res Commun (2007) 1.25
The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci (2013) 1.20
Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett (2010) 1.18
Nanoimaging for protein misfolding diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.15
Loop-mediated isothermal amplification for rapid detection of Bacillus anthracis spores. Biotechnol Lett (2007) 1.14
Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep (2014) 1.13
Estrogen stimulates estrogen-related receptor alpha gene expression through conserved hormone response elements. Endocrinology (2003) 1.11
Functional mechanism of the abscisic acid agonist pyrabactin. J Biol Chem (2010) 1.11
Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev (2012) 1.11
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells (2007) 1.09
CobB regulates Escherichia coli chemotaxis by deacetylating the response regulator CheY. Mol Microbiol (2010) 1.08
Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J Nutr Biochem (2011) 1.08
Crystal structure of methyl parathion hydrolase from Pseudomonas sp. WBC-3. J Mol Biol (2005) 1.06
Crystal structure of DNA gyrase B' domain sheds lights on the mechanism for T-segment navigation. Nucleic Acids Res (2009) 1.03
The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). Nucleic Acids Res (2006) 1.03
Visualizing the dynamic behavior of poliovirus plus-strand RNA in living host cells. Nucleic Acids Res (2005) 1.03
In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antiviral Res (2011) 1.02
Genetic modification of glucose oxidase for improving performance of an amperometric glucose biosensor. Biosens Bioelectron (2002) 1.01
Molecular mechanism of misfolding and aggregation of Aβ(13-23). J Phys Chem B (2013) 1.01
Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin (2012) 1.00
Characterization of highly pathogenic H5N1 avian influenza viruses isolated from poultry markets in central China. Virus Res (2009) 0.97
Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes (2008) 0.96
Identification of novel 14-3-3ζ interacting proteins by quantitative immunoprecipitation combined with knockdown (QUICK). J Proteome Res (2010) 0.96
New regulatory mechanisms for the intracellular localization and trafficking of influenza A virus NS1 protein revealed by comparative analysis of A/PR/8/34 and A/Sydney/5/97. J Gen Virol (2010) 0.96
DNA probe functionalized QCM biosensor based on gold nanoparticle amplification for Bacillus anthracis detection. Biosens Bioelectron (2011) 0.96
Plasmid-borne catabolism of methyl parathion and p-nitrophenol in Pseudomonas sp. strain WBC-3. Biochem Biophys Res Commun (2005) 0.95
Effects of microtubule modulators on HIV-1 infection of transformed and resting CD4 T cells. J Virol (2011) 0.95
Seeing mutations in living cells. Curr Biol (2010) 0.94
Phage display mediated immuno-PCR. Nucleic Acids Res (2006) 0.94
Construction of single chain variable fragment (ScFv) and BiscFv-alkaline phosphatase fusion protein for detection of Bacillus anthracis. Anal Chem (2006) 0.94
The tegument protein UL94 of human cytomegalovirus as a binding partner for tegument protein pp28 identified by intracellular imaging. Virology (2009) 0.94
Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep (2013) 0.93
Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China. J Int Med Res (2009) 0.93
Adult renal mesenchymal stem cell-like cells contribute to juxtaglomerular cell recruitment. J Am Soc Nephrol (2013) 0.93
Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials (2007) 0.93
Oligonucleotide ligation assay-based DNA chip for multiplex detection of single nucleotide polymorphism. Biosens Bioelectron (2004) 0.92
Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication. J Virol (2010) 0.91
Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology. Stem Cells (2013) 0.91
Rapid detection of Bacillus anthracis using monoclonal antibody functionalized QCM sensor. Biosens Bioelectron (2008) 0.91
Rapid detection of Bacillus anthracis spores using a super-paramagnetic lateral-flow immunological detection system. Biosens Bioelectron (2012) 0.89
Crystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosis. Cell Res (2013) 0.89
D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm (2014) 0.88
Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2013) 0.88
Three-dimensional gold nanoparticle clusters with tunable cores templated by a viral protein scaffold. Small (2012) 0.88
Gold nanoparticle enhanced immuno-PCR for ultrasensitive detection of Hantaan virus nucleocapsid protein. J Immunol Methods (2009) 0.88
Reduction of dopamine level enhances the attractiveness of male Drosophila to other males. PLoS One (2009) 0.88
pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Biomacromolecules (2013) 0.88
Escherichia coli mismatch repair protein MutL interacts with the clamp loader subunits of DNA polymerase III. Mutat Res (2007) 0.87
Seeding-induced self-assembling protein nanowires dramatically increase the sensitivity of immunoassays. Nano Lett (2009) 0.87
Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small (2009) 0.87
Integration of a fluorescent molecular biosensor into self-assembled protein nanowires: a large sensitivity enhancement. Angew Chem Int Ed Engl (2010) 0.87
Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale (2013) 0.87
Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method. PLoS One (2011) 0.87
Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine (Lond) (2012) 0.87
Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo. Mar Drugs (2013) 0.87
Analysis of Biological Samples Using Paper Spray Mass Spectrometry: An Investigation of Impacts by the Substrates, Solvents and Elution Methods. Chromatographia (2013) 0.86
Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. Nanoscale (2011) 0.86
C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway. Circ Res (2013) 0.86
Identification and characterization of Bacillus anthracis by multiplex PCR on DNA chip. Biosens Bioelectron (2004) 0.86
Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm (2013) 0.86
Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb Cell Fact (2012) 0.86
Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy. Antimicrob Agents Chemother (2010) 0.85
Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother (2013) 0.85
Quantum dot-aptamer nanoprobes for recognizing and labeling influenza A virus particles. Nanoscale (2011) 0.85
Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation. Mol Microbiol (2011) 0.84
Viral coat proteins as flexible nano-building-blocks for nanoparticle encapsulation. Small (2010) 0.84
Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies. PLoS One (2009) 0.84
Crystal structure of DNA polymerase III β sliding clamp from Mycobacterium tuberculosis. Biochem Biophys Res Commun (2011) 0.84
Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci. Microb Biotechnol (2014) 0.84